MAPT and Alzheimer disease: Our findings suggest that there are isoform-driven differences between the phospho-tau interactome in fetal and Alzheimer’s disease brain, including differences in interaction with the critical 14-3-3 family of protein chaperones, which may explain, in part, the resilience of fetal brain to tau toxicity.